Apricoxib Terminated Phase N/A Trials for Lung Cancer Non-Small Cell Cancer (NSCLC) Prevention

IndicationsStatusPurposePhase
TerminatedPreventionNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01532362Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer